These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 10714504)

  • 1. Construction of HIV Rev peptides containing peptide nucleic acid that bind HIV RRE IIB RNA.
    Kumagai I; Takahashi T; Hamasaki K; Ueno A; Mihara H
    Bioorg Med Chem Lett; 2000 Feb; 10(4):377-9. PubMed ID: 10714504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of artificial pepetides that recognize the HIV RRE IIB RNA.
    Takahashi T; Kumagai I; Hamasaki K; Ueno A; Mihara H
    Nucleic Acids Symp Ser; 1999; (42):271-2. PubMed ID: 10780484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide-triggered conformational switch in HIV-1 RRE RNA complexes.
    Gosser Y; Hermann T; Majumdar A; Hu W; Frederick R; Jiang F; Xu W; Patel DJ
    Nat Struct Biol; 2001 Feb; 8(2):146-50. PubMed ID: 11175904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereospecificity of short Rev-derived peptide interactions with RRE IIB RNA.
    Litovchick A; Rando RR
    RNA; 2003 Aug; 9(8):937-48. PubMed ID: 12869705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proflavine acts as a Rev inhibitor by targeting the high-affinity Rev binding site of the Rev responsive element of HIV-1.
    DeJong ES; Chang CE; Gilson MK; Marino JP
    Biochemistry; 2003 Jul; 42(26):8035-46. PubMed ID: 12834355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exchange of the basic domain of human immunodeficiency virus type 1 Rev for a polyarginine stretch expands the RNA binding specificity, and a minimal arginine cluster is required for optimal RRE RNA binding affinity, nuclear accumulation, and trans-activation.
    Nam YS; Petrovic A; Jeong KS; Venkatesan S
    J Virol; 2001 Mar; 75(6):2957-71. PubMed ID: 11222721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV Rev peptides conjugated with peptide nucleic acids and their efficient binding to RRE RNA.
    Kumagai I; Takahashi T; Hamasaki K; Ueno A; Mihara H
    Bioorg Med Chem Lett; 2001 May; 11(9):1169-72. PubMed ID: 11354369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arginine side-chain dynamics in the HIV-1 rev-RRE complex.
    Wilkinson TA; Botuyan MV; Kaplan BE; Rossi JJ; Chen Y
    J Mol Biol; 2000 Nov; 303(4):515-29. PubMed ID: 11054288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of mismatch-binding ligands as inhibitors for Rev-RRE interaction.
    Nakatani K; Horie S; Goto Y; Kobori A; Hagihara S
    Bioorg Med Chem; 2006 Aug; 14(15):5384-8. PubMed ID: 16603366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A molecular rheostat. Co-operative rev binding to stem I of the rev-response element modulates human immunodeficiency virus type-1 late gene expression.
    Mann DA; Mikaélian I; Zemmel RW; Green SM; Lowe AD; Kimura T; Singh M; Butler PJ; Gait MJ; Karn J
    J Mol Biol; 1994 Aug; 241(2):193-207. PubMed ID: 8057359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA-ligand interactions: affinity and specificity of aminoglycoside dimers and acridine conjugates to the HIV-1 Rev response element.
    Luedtke NW; Liu Q; Tor Y
    Biochemistry; 2003 Oct; 42(39):11391-403. PubMed ID: 14516190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An alpha-helical peptidomimetic inhibitor of the HIV-1 Rev-RRE interaction.
    Mills NL; Daugherty MD; Frankel AD; Guy RK
    J Am Chem Soc; 2006 Mar; 128(11):3496-7. PubMed ID: 16536504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity of RSG-1.2 peptide binding to RRE-IIB RNA element of HIV-1 over Rev peptide is mainly enthalpic in origin.
    Kumar S; Bose D; Suryawanshi H; Sabharwal H; Mapa K; Maiti S
    PLoS One; 2011; 6(8):e23300. PubMed ID: 21853108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The amino terminal domain of HIV-1 Rev is required for discrimination of the RRE from nonspecific RNA.
    Daly TJ; Doten RC; Rusche JR; Auer M
    J Mol Biol; 1995 Oct; 253(2):243-58. PubMed ID: 7563086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha helix-RNA major groove recognition in an HIV-1 rev peptide-RRE RNA complex.
    Battiste JL; Mao H; Rao NS; Tan R; Muhandiram DR; Kay LE; Frankel AD; Williamson JR
    Science; 1996 Sep; 273(5281):1547-51. PubMed ID: 8703216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specificity of aminoglycoside binding to RNA constructs derived from the 16S rRNA decoding region and the HIV-RRE activator region.
    Wang Y; Hamasaki K; Rando RR
    Biochemistry; 1997 Jan; 36(4):768-79. PubMed ID: 9020774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of HIV Rev peptides with the Rev response element RNA.
    Williamson JR; Battiste JL; Mao H; Frankel AD
    Nucleic Acids Symp Ser; 1995; (33):46-8. PubMed ID: 8643394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-time kinetics of HIV-1 Rev-Rev response element interactions. Definition of minimal binding sites on RNA and protein and stoichiometric analysis.
    Van Ryk DI; Venkatesan S
    J Biol Chem; 1999 Jun; 274(25):17452-63. PubMed ID: 10364175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probing the details of the HIV-1 Rev-Rev-responsive element interaction: effects of modified nucleotides on protein affinity and conformational changes during complex formation.
    Renwick SB; Critchley AD; Adams CJ; Kelly SM; Price NC; Stockley PG
    Biochem J; 1995 Jun; 308 ( Pt 2)(Pt 2):447-53. PubMed ID: 7772026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational analysis of the HIV-1 Rev protein and its target sequence, the Rev responsive element.
    Olsen HS; Beidas S; Dillon P; Rosen CA; Cochrane AW
    J Acquir Immune Defic Syndr (1988); 1991; 4(6):558-67. PubMed ID: 2023097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.